EyePoint Pharmaceuticals News

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

May 15 04:46

EyePoint Pharmaceuticals | 10-Q: Quarterly report

May 9 22:17

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Cormorant Asset Management, LP

May 9 05:03

EyePoint Pharmaceuticals | 8-K: EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments

May 8 19:08

EyePoint Pharmaceuticals | 8-K: Current report

May 6 21:28

EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Management, L.P.(9.90%),Robert Atchinson(9.90%), etc.

May 2 05:12

EyePoint Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Management, L.P.(10.35%),Robert Atchinson(10.35%), etc.

May 1 08:57

EyePoint Pharmaceuticals | DEFA14A: Others

Apr 27 04:06

EyePoint Pharmaceuticals | DEF 14A: Definitive information statements

Apr 27 04:06

EyePoint Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner Adage Capital Management, L.P.

Apr 23 04:18

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Cormorant Asset Management, LP

Apr 23 04:02

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Paggiarino Dario A.

Apr 3 05:30

EyePoint Pharmaceuticals | 10-K: Annual report

Mar 9 02:56

EyePoint Pharmaceuticals | 8-K: EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments

Mar 7 20:09

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ribeiro Ramiro

Mar 5 06:46

EyePoint Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Ribeiro Ramiro

Mar 5 06:43

EyePoint Pharmaceuticals | 8-K: Current report

Mar 4 20:05

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.

Feb 29 11:31

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.

Feb 23 06:14

EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(6.1%),Peter Kolchinsky(6.1%), etc.

Feb 15 10:13